GlaxoSmithKline Cuts 200 Jobs at U.K. Antibiotics Plant
GlaxoSmithKline Cuts 200 Jobs at U.K. Antibiotics Plant
GALWAY, IRELAND--October 22, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) is planning to cut almost 200 jobs at its antibiotics manufacturing plant in Ulverston, U.K., as the company continues with its drive to cut costs.
Within this article: Details planned job cuts, related plant closures and cost-cutting
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- GlaxoSmithKline Shutting Irish Skincare Plant
- And so it Grows...European Pharmaceutical-Biotech Industry Investing Billio...
- Power Industry Leads Montana's $1.4 Billion in Projects Under Construction
- GlaxoSmithKline Axing 720 at Belgian Vaccines Hub
- GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal